A former MIT engineer, Jamie Heywood is founder and chairman of PatientsLikeMe, where he provides the scientific vision and architecture for its patient-centered medical platform. In 1999, Jamie founded the ALS Therapy Development Institute (ALS TDI), the world's first non-profit biotechnology company, where he served as CEO until 2007. Pioneering an open research model and an industrialized therapeutic validation process, Jamie led ALS TDI to become the world's largest and most comprehensive ALS research program.

The scientific and business innovations Jamie developed at ALS TDI and PatientsLikeMe have been transforming the intersection of biotechnology and pharmaceutical development, personalized medicine, and patient care.